COMP <GO>
NMRA vs CRDF // PIOTROSKI F-SCORE QUALITY
Neumora Therapeutics Inc. (NASDAQ) VS. Cardiff Oncology Inc. (NASDAQ) • 15-METRIC TALLY: NMRA 2
— CRDF 1
▲ PIOTROSKI F-SCORE QUALITY LEADER: NMRA
LAST: $0.37 (-5.43%) • MKT CAP: $73.0M
piotroski-score
3/9
LAST: $0.89 (-2.46%) • MKT CAP: $70.9M
piotroski-score
1/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NMRA VS. CRDF)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NMRA | CRDF | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | -60.00% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -7.70% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | -13.20% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 3/9 | 1/9 | +2.00 | NMRA | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 28.8 | 38.9 | -10.08 | CRDF | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $73.0M | $70.9M | $2.0M | NMRA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NMRA REV | CRDF REV | NMRA GROSS % | CRDF GROSS % | NMRA FCF | CRDF FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $593.0K | — | — | -$206.4M | -$38.0M |
| FY 2024 | $0 | $683.0K | — | — | -$182.9M | -$37.8M |
| FY 2023 | $0 | $488.0K | — | — | -$163.3M | -$30.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NMRA // BETA —
CRDF // BETA —